Downregulation of endogenous intermedin augmented myocardial injury in rats with ischemia/reperfusion

Hormone and Metabolic Research

Volumn 45, Issue 3, 2013, Pages 206-212

  Teng, X ^a,b,c   Bian, Y ^d   Cai, Y ^a   Duan, X ^e   Yuan, F ^b   Du, J ^a   Wu, W ^e   Wang, X ^e   Tang, C ^a,e   Qi, Y ^a,e  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HEBEI MEDICAL UNIVERSITY   (China)

^c Hebei Key Laboratory of Laboratory Animal Science   (China)

^d SHANXI MEDICAL UNIVERSITY   (China)

^e BEIJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS   (China)

Author keywords

calcitonin receptor like receptor; cardiomyocytes; hypoxia reoxygenation injury; receptor activity modifying proteins

Indexed keywords

CALCITONIN RECEPTOR LIKE RECEPTOR; INTERMEDIN; RECEPTOR ACTIVITY MODIFYING PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY LIGATION; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; HEART MUSCLE; HEART MUSCLE CELL; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HYPOXIA; MALE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RADIOIMMUNOASSAY; RAT; REOXYGENATION; UPREGULATION; WESTERN BLOTTING;

ADRENOMEDULLIN; ANIMALS; ANIMALS, NEWBORN; CALCITONIN RECEPTOR-LIKE PROTEIN; DOWN-REGULATION; ELECTROCARDIOGRAPHY; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; MYOCYTES, CARDIAC; NEUROPEPTIDES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR ACTIVITY-MODIFYING PROTEINS;

RATTUS;

EID: 84875210800     PISSN: 00185043     EISSN: 14394286     Source Type: Journal    
DOI: 10.1055/s-0032-1327572     Document Type: Article

References (28)

1. Moens A. L., Claeys M. J., Timmermans J. P., Vrints C. J. Myocardial ischemia/reperfusion injury, a clinical view on a complex pathophysiological process. Int J Cardiol: 2005; 100 179 190
2. Dorweiler B., Pruefer D., Andrasi T. B., Maksan S. M., Schmiedt W., Neufang A., Vahl C. F. Ischemia-reperfusion injury: pathlophysiology and clinical implications. Eur J Trauma Emerg Surg: 2007; 33 600 612
3. Prabhu S. D. Cytokine-induced modulation of cardiac function. Circ Res: 2004; 95 1140 1153 (Pubitemid 39648205)
4. Burley D. S., Hamid S. A., Baxter G. F. Cardioprotective actions of peptide hormones in myocardial ischemia. Heart Fail Rev: 2007; 12 279 291 (Pubitemid 350176701)
5. Roh J., Chang C. L., Bhalla A., Klein C., Hsu S. Y. Intermedin is a calcitonin/calcitonin gene-related peptide family peptide acting through the calcitonin receptor-like receptor/receptor activity-modifying protein receptor complexes. J Biol Chem: 2004; 279 7264 7274 (Pubitemid 38248876)
6. Takei Y., Inoue K., Ogoshi M., Kawahara T., Bannai H., Miyano S. Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator. FEBS Lett: 2004; 556 53 58 (Pubitemid 38058554)
7. Yang J. H., Jia Y. X., Pan C. S., Zhao J., Ouyang M., Yang J., Tang C. S., Qi Y. F. Effects of intermedin (1-53) on cardiac function and ischemia/reperfusion injury in isolated rat hearts. Biochem Biophys Res Commun: 2005; 327 713 719 (Pubitemid 40092808)
8. Ren Y. S., Yang J. H., Zhang J., Pan C. S., Yang J., Zhao J., Pang Y. Z., Tang C. S., Qi Y. F. Intermedin 1-53 in central nervous system elevates arterial blood pressure in rats. Peptides: 2006; 27 74 79 (Pubitemid 43061039)
9. Bell D., McDermott B. J. Intermedin (adrenomedullin-2): a novel counter-regulatory peptide in the cardiovascular and renal systems. Br J Pharmacol: 2008; 153 S247 S262 (Pubitemid 351340982)
10. Grossini E., Molinari C., Mary D. A., Uberti F., Caimmi P. P., Vacca G. Intracoronary intermedin 1-47 augments cardiac perfusion and function in anesthetized pigs: role of calcitonin receptors and {beta}-adrenoreceptor- mediated nitric oxide release. J Appl Physiol: 2009; 107 1037 1050
11. Jolly L., March J. E., Kemp P. A., Bennett T., Gardiner S. M. Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats. Br J Pharmacol: 2009; 157 1502 1513
12. Yang J. H., Cai Y., Duan X. H., Ma C. G., Wang X., Tang C. S., Qi Y. F. Intermedin 1-53 inhibits rat cardiac fibroblast activation induced by angiotensin II. Regul Pept: 2009; 158 19 25
13. Smith R. S. Jr, Gao L., Bledsoe G., Chao L., Chao J. Intermedin is a new angiogenic growth factor. Am J Physiol Heart Circ Physiol: 2009; 297 H1040 H1047
14. Pearson L. J., Yandle T. G., Nicholls M. G., Evans J. J. Intermedin (adrenomedullin-2): a potential protective role in human aortic endothelial cells. Cell Physiol Biochem: 2009; 23 97 108
15. Pfeil U., Aslam M., Paddenberg R., Quanz K., Chang C. L., Park J. I., Gries B., Rafiq A., Faulhammer P., Goldenberg A., Papadakis T., Noll T., Hsu SY T., Weissmann N., Kummer W. Intermedin/adrenomedullin-2 is a hypoxia-induced endothelial peptide that stabilizes pulmonary microvascular permeability. Am J Physiol Lung Cell Mol Physiol: 2009; 297 L837 L845
16. Hagiwara M., Bledsoe G., Yang Z. R., Smith R. S. Jr, Chao L., Chao J. Intermedin ameliorates vascular and renal injury by inhibition of oxidative stress. Am J Physiol Renal Physiol: 2008; 295 F1735 F1743
17. Jia Y. X., Yang J. H., Pan C. S., Geng B., Zhang J., Xiao Y., Tang C. S., Qi Y. F. Intermedin1-53 protects the heart against isoproterenol-induced ischemic injury in rats. Eur J Pharmacol: 2006; 549 117 123 (Pubitemid 44441261)
18. Song J. Q., Teng X., Cai Y., Tang C. S., Qi Y. F. Activation of Akt/GSK-3beta signaling pathway is involved in intermedin(1-53) protection against myocardial apoptosis induced by ischemia/reperfusion. Apoptosis: 2009; 14 1061 1069
19. Zhang H. Y., Jiang W., Liu J. Y., Li Y., Chen C. L., Xin H. B., Huang D. J. Intermedin is upregulated and has protective roles in a mouse ischemia/reperfusion model. Hypertens Res: 2009; 32 861 868
20. Esumi K., Nishida M., Shaw D., Smith T. W., Marsh J. D. NADH measurements in adult rat myocytes during simulated ischemia. Am J Physiol: 1991; 260 H1743 H1752
21. Elz J. S., Nayler W. G. Quantification of calcium paradox in neonatal rat hearts. Am J Physiol: 1987; 253 H1358 H1364
22. Askawa T., Matashushita S. Thiobarbituric acid test for detecting lipid peroxide. Lipids: 1979; 14 401 406
23. Chauhan M., Yallampalli U., Reed L., Yallampalli C. Adrenomedullin 2 Antagonist Infusion to Rats During Midgestation Causes Fetoplacental Growth Restriction Through Apoptosis. Biol Reprod: 2006; 75 940 947 (Pubitemid 44845601)
24. White M. M., Samson W. K. Intermedin 17-47 does not function as a full intermedin antagonist within the central nervous system or pituitary. Peptides: 2007; 28 2171 2178 (Pubitemid 47600420)
25. Zeng Q., Yuan Y., Wang X., Wu H. M., Fan L., Qi Y. F., Tang C. S., Cai Y., Pan C. S. Upregulated expression of intermedin and its receptor in the myocardium and aorta in spontaneously hypertensive rats. Peptides: 2009; 30 391 399
26. Hirose T., Totsune K., Mori N., Morimoto R., Hashimoto M., Nakashige Y., Metoki H., Asayama K., Kikuya M., Ohkubo T., Hashimoto J., Sasano H., Kohzuki M., Takahashi K., Imai Y. Increased expression of adrenomedullin 2/intermedin in rat hearts with congestive heart failure. Eur J Heart Fail: 2008; 10 840 849
27. Hirose T., Totsune K., Mori N., Mori T., Morimoto R., Metoki H., Asayama K., Kikuya M., Ohkubo T., Kohzuki M., Takahashi K., Imai Y. Expression of adrenomedullin 2/intermedin, a possible reno-protective peptide, is decreased in the kidneys of rats with hypertension or renal failure. Am J Physiol Renal Physiol: 2010; 299 F128 F134
28. Bell D., Zhao Y., McCoy F. P., Devine A., McDermott B. J. Expression of the counter-regulatory peptide intermedin is augmented in the presence of oxidative stress in hypertrophied cardiomyocytes. Cell Physiol Biochem: 2008; 21 409 420 (Pubitemid 351620294)